Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B

[Guest guest]

Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B11th Online Posting Now Available

Hepatocellular carcinoma (HCC) is a highly lethal complication of cirrhosis and chronic viral hepatitis. Patients with hepatitis B virus (HBV) infection are 100 times more likely to develop HCC than uninfected persons. Given that chronic viral hepatitis is such an important cause of HCC, and that this cancer has such a poor prognosis, it is critical to consider whether viral hepatitis-related HCC can be prevented.

In Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B, M. Di Bisceglie, MD, FACP, examines recent evidence suggesting that antiviral therapy may play a significant role in preventing both primary development of HCC as well as its recurrence in patients with chronic HBV infection.

Read the 11th online posting now at www.projectsinknowledge.com/HBVpostings/.